Cardinal Health Cash Flow from Financial Activities 2010-2024 | CAH

Cardinal Health annual/quarterly cash flow from financial activities history and growth rate from 2010 to 2024. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
  • Cardinal Health cash flow from financial activities for the quarter ending March 31, 2024 was $0.012B, a 100.49% decline year-over-year.
  • Cardinal Health cash flow from financial activities for the twelve months ending March 31, 2024 was $-4.724B, a 37.92% decline year-over-year.
  • Cardinal Health annual cash flow from financial activities for 2023 was $-3.051B, a 23.87% increase from 2022.
  • Cardinal Health annual cash flow from financial activities for 2022 was $-2.463B, a 87.02% increase from 2021.
  • Cardinal Health annual cash flow from financial activities for 2021 was $-1.317B, a 40.14% decline from 2020.
Cardinal Health Annual Cash Flow Financial
(Millions of US $)
2023 $-3,051
2022 $-2,463
2021 $-1,317
2020 $-2,200
2019 $-2,293
2018 $-2,276
2017 $3,746
2016 $-1,139
2015 $60
2014 $-710
2013 $275
2012 $-454
2011 $-193
2010 $-727
2009 $-468
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.982B $205.012B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.312B 20.57
Becton Dickinson (BDX) United States $68.532B 19.39
West Pharmaceutical Services (WST) United States $24.968B 44.75
Align Technology (ALGN) United States $20.133B 38.87
Cooper (COO) United States $19.321B 29.24
Labcorp (LH) United States $17.436B 15.01
Henry Schein (HSIC) United States $9.408B 16.74
DENTSPLY SIRONA (XRAY) United States $5.839B 15.12
Merit Medical Systems (MMSI) United States $4.826B 26.45
CONMED (CNMD) United States $2.320B 21.04
Patterson (PDCO) United States $2.260B 10.82
STAAR Surgical (STAA) United States $2.103B 80.75
Atrion (ATRI) United States $0.831B 44.40
Lifevantage (LFVN) United States $0.091B 11.77
Pro-Dex (PDEX) United States $0.066B 33.28
Biolase (BIOL) United States $0.005B 0.00